International Patent: TARGETED PROTEIN DEGRADATION CHIMERA CYTOTAC, AND USE THEREOF

GENEVA, Aug. 21 -- EAST CHINA NORMAL UNIVERSITY filed a patent application (CN2026/075047) for “TARGETED PROTEIN DEGRADATION CHIMERA CYTOTAC, AND USE THEREOF”. With publication no. WO/2026/170996, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 19/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....